F8 is not the only protein with this significant issue; our group has shown similar findings for CFTR [55], which have risen in relevance as triple-therapy treatments for cystic fibrosis have disproportionately failed in non-European individuals who lack the delta 508 change observed in most European individuals. The gene discussed is F8; the disease is cystic fibrosis.